Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. 4 Option exercise EVP & Chief Medical Officer acquired 80,000 shares (option exercise)
  5. 8-K Event Exit or restructuring costs
  6. 8-K Event Material agreement · Agreement ended
  7. S-3ASR Offering Registration Statement
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 4 Other disposition Director disposed of 6,405 shares (other)
  11. 4 Other disposition Director disposed of 3,500,000 shares (other)
  12. 8-K Event Material agreement
  13. 8-K Event Executive or director change
  14. 4 Other disposition Director disposed of 5,377,590 shares (other)
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 8-K Event Results of operations · Other events
  18. 4 Open-market sale 10% owner sold 700 shares at $25.11 ($17,577)
  19. 4 Planned sale Director sold 18,000 shares at $24.66 ($443,916)
  20. 4 Open-market sale 10% owner sold 96,952 shares at an average $25.17 ($2,440,652)

Page 14 of 41 · 806 filings